Scrip
US FDA clears Lupin's Mandideep facility
21 January 2010
Anju Ghangurde
The US
FDA has cleared
Lupin's Mandideep facility in India, after the company addressed all concerns related to the warning letter issued by the agency last May.
The company said that it had received official communication from the FDA on the satisfactory resolution of the warning letter. "In...
Please Login to read the full article.
21 January 2010
Anju Ghangurde
The company said that it had received official communication from the FDA on the satisfactory resolution of the warning letter. "In...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
SCIENCE
- Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development
- Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
